Browse > Article
http://dx.doi.org/10.5115/acb.2010.43.2.110

$CDH_3$/P-Cadherin regulates migration of $HuCCT_1$ cholangiocarcinoma cells  

Baek, Sung-Min (Department of Anatomy, School of Medicine, Pusan National University)
Lee, Yong-Whan (Department of Anatomy, School of Medicine, Pusan National University)
Yoon, Sik (Department of Anatomy, School of Medicine, Pusan National University)
Baek, Sun-Yong (Department of Anatomy, School of Medicine, Pusan National University)
Kim, Bong-Seon (Department of Anatomy, School of Medicine, Pusan National University)
Oh, Sae-Ock (Department of Anatomy, School of Medicine, Pusan National University)
Publication Information
Anatomy and Cell Biology / v.43, no.2, 2010 , pp. 110-117 More about this Journal
Abstract
Intrahepatic cholangiocarcinoma is the second most common subtype of primary hepatobilliary cancer. Despite advances in surgical and medical therapy, its survival rate remains poor. Compared to hepatocellular carcinoma (HCC), the most common liver malignancy, the underlying mechanisms of cholangiocarcinoma carcinogenesis are poorly characterized. P-cadherin (CDH3) is a cadherin super family member. Although CDH3 is frequently over-expressed in cholangiocarcinoma tissues, its roles have never been characterized. To determine the roles of CDH3 in cholangiocarcinoma, we investigated CDH3 function in HuCCT1 cells using specific siRNA. Transfection with CDH3 siRNA did not affect proliferation of HuCCT1 cells. However, cell migration and invasion were significantly reduced when CDH3 was down-regulated. In addition, expressions of several biomarkers for epithelial-mesenchymal transition (EMT) were not changed by CDH3 down-regulation. These results suggest that CDH3 regulates cell migration independent of EMT in cholangiocarcinoma cells.
Keywords
Cholangiocarcinoma; CDH3; migration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Stefansson IM, Salvesen HB, Akslen LA. (2004). Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. J Clin Oncol 22: 1242-1252   DOI   ScienceOn
2 Cheung LW, Leung PC, Wong AS. (2010). Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer. Oncogene 29: 2427-2440   DOI   ScienceOn
3 Obama K, Ura K, Li M, et al. (2005). Genome-wide anal ysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology 41: 1339-1348   DOI   ScienceOn
4 Peralta Soler A, Knudsen KA, Salazar H, Han AC, Keshgegian AA. (1999). P-cadherin expression in breast carcinoma indicates poor survival. Cancer 86: 1263-1272   DOI   ScienceOn
5 Paredes J, Correia AL, Ribeiro AS, Milanezi F, Cameselle-Teijeiro J, Schmitt FC. (2008). Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival. J Clin Pathol 61: 856-862   DOI   ScienceOn
6 Pece S, Gutkind JS. (2000). Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem 275: 41227-41233   DOI   ScienceOn
7 Nose A, Takeichi M. (1986). A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos. J Cell Biol 103: 2649-2658   DOI   ScienceOn
8 Kato I, Kuroishi T, Tominaga S. (1990). Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan. Jpn J Clin Oncol 20: 232-237
9 Kinch MS, Clark GJ, Der CJ, Burridge K. (1995). Tyrosine phosphorylation regulates the adhesions of rastransformed breast epithelia. J Cell Biol 130: 461-471   DOI   ScienceOn
10 Milicic A, Harrison LA, Goodlad RA, et al. (2008). Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fi ssion in vivo. Cancer Res 68: 7760-7768   DOI   ScienceOn
11 Olnes MJ, Erlich R. (2004). A review and update on cholangiocarcinoma. Oncology 66: 167-179   DOI   ScienceOn
12 Hibi K, Goto T, Mizukami H, et al. (2009a). Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer. Anticancer Res 29: 2215-2217
13 Paredes J, Albergaria A, Oliveira JT, Jeronimo C, Milanezi F, Schmitt FC. (2005). P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res 11: 5869-5877   DOI   ScienceOn
14 Gorski JJ, James CR, Quinn JE, et al. (2009). BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Res Treat [Epub ahead of print]
15 Hay E, Nouraud A, Marie PJ. (2009). N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling. PLoS One 4: e8284   DOI   ScienceOn
16 Hibi K, Kitamura YH, Mizukami H, et al. (2009b). Frequent CDH3 demethylation in advanced gastric carcinoma. Anticancer Res 29: 3945-3947
17 Imai K, Hirata S, Irie A, et al. (2008). Identifi cation of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers. Clin Cancer Res 14: 6487-6495   DOI   ScienceOn
18 Dasgupta S, Tripathi PK, Qin H, Bhattacharya-Chatterjee M, Valentino J, Chatterjee SK. (2006). Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma. Oral Oncol 42: 306-316   DOI   ScienceOn
19 Jeon TY, Han ME, Lee YW, et al. (2010). Overexpression of stathmin1 in the diff use type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. Br J Cancer 102: 710-718   DOI   ScienceOn
20 Anastasiadis PZ, Reynolds AB. (2001). Regulation of Rho GTPases by p120-catenin. Curr Opin Cell Biol 13: 604-610   DOI   ScienceOn
21 Gamallo C, Moreno-Bueno G, Sarrio D, Calero F, Hardisson D, Palacios J. (2001). The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Mod Pathol 14: 650-654   DOI   ScienceOn
22 Zeisberg M, Neilson EG. (2009). Biomarkers for epithelialmesenchymal transitions. J Clin Invest 119: 1429-1437   DOI   ScienceOn
23 Thiery JP, Acloque H, Huang RY, Nieto MA. (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890   DOI   ScienceOn
24 van Roy FM, McCrea PD. (2005). A role for Kaiso-p120ctn complexes in cancer? Nat Rev Cancer 5: 956-964   DOI   ScienceOn
25 Yilmaz M, Christofori G. (2009). EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33   DOI   ScienceOn
26 Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. (1997). Increase in primary liver cancer in the UK, 1979-94. Lancet 350: 1142-1143
27 Suyama K, Shapiro I, Guttman M, Hazan RB. (2002). A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301-314   DOI   ScienceOn
28 Takeichi M. (1995). Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7: 619-627   DOI   ScienceOn
29 Taniuchi K, Nakagawa H, Hosokawa M, et al. (2005). Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res 65: 3092-3099   DOI
30 Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR. (2004). E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. Embo J 23: 1739-1748   DOI   ScienceOn
31 Shaib YH, Davila JA, McGlynn K, El-Serag HB. (2004). Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40: 472-477   DOI   ScienceOn
32 Simpson KJ, Selfors LM, Bui J, et al. (2008). Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 10: 1027-1038   DOI   ScienceOn
33 Staddon JM, Smales C, Schulze C, Esch FS, Rubin LL. (1995). p120, a p120-related protein (p100), and the cadherin/catenin complex. J Cell Biol 130: 369-381   DOI   ScienceOn